Other languages Pulmonx Corporation

Equities

LUNG

US7458481014

Market Closed - Nasdaq Other stock markets 01:30:00 03/05/2024 am IST			5-day change	1st Jan Change
9.38 ^USD	+21.50%		+28.49%	-26.43%

01/05	Earnings Flash (LUNG) PULMONX CORPORATION Posts Q1 Revenue $18.9M, vs. Street Est of $17.9M	MT
01/05	Transcript : Pulmonx Corporation, Q1 2024 Earnings Call, May 01, 2024

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Pulmonx Corporation Provides Revenue Guidance for the Full Year 2024	02/05
Pulmonx Corporation Reports Earnings Results for the First Quarter Ended March 31, 2024	02/05
Pulmonx kondigt behandeling aan van de eerste patiënt met het AeriSeal®-systeem in de CONVERT II-studie	27/02
Pulmonx meldet Behandlung des ersten Patienten mit dem AeriSeal®-System in der CONVERT-II-Zulassungsstudie	27/02
Pulmonx annonce le traitement du premier patient par système AeriSeal® dans l'essai pivot CONVERT II	27/02
Pulmonx annuncia il trattamento del primo paziente con il sistema AeriSeal® nello studio pivotale CONVERT II	27/02
Pulmonx anuncia el tratamiento del primer paciente con el sistema AeriSeal® en el ensayo pivotal CONVERT II	27/02
Pulmonx Corporation Announces Treatment of the First Patient with the Aeriseal System in Convert II Pivotal Trial	26/02
Pulmonx Shares Fall After Wells Fargo Downgrade	24/02
Pulmonx Corporation Provides Earnings Guidance for the Full Year 2024	22/02
Pulmonx Corporation Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	22/02
Pulmonx Corporation Announces Chief Executive Officer Changes, Effective March 15, 2024	22/02
Pulmonx Corporation Announces Executive Changes, Effective March 15, 2024	22/02
Pulmonx Insider Sold Shares Worth $292,000, According to a Recent SEC Filing	20/02
MÄRKTE USA/Wenig verändert vor Fed - Dow von Caterpillar und Amgen belastet	31/23/31
MÄRKTE USA/US-Börsen eröffnen im Minus - Renditen als Taktgeber	31/23/31
MÄRKTE USA/US-Börsen von Renditerückgang gestützt	31/23/31
Pulmonx Corporation Provides Earnings Guidance for 2023	31/23/31
Pulmonx Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	31/23/31
Pulmonx Finance Chief Derrick Sung Leaves, John McKune Named Interim CFO; Preliminary Q3 Revenue Issued	11/23/11

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Pulmonx Corporation

Equities

LUNG

US7458481014

Other languages

Filters